Vestal Point Capital’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.63M Buy
420,000
+1,449
+0.3% +$15.8K 0.09% 53
2026
Q2
$5.24M Sell
418,551
-10,000
-2% -$134K 0.12% 60
2026
Q1
$6.39M Sell
428,551
-1,221,449
-74% -$27.2M 0.18% 71
2025
Q4
$41.2M Buy
+1,650,000
New +$29.4M 1.4% 24

Other funds holding OLMA

Vestal Point Capital's OLMA Position: Q3 2026 in Review

Vestal Point Capital increased its Olema Oncology (OLMA) stake by 0.35% in Q3 2026, buying an estimated $15.8K and bringing the position to 420,000 shares worth $3.63M. The position accounts for 0.09% of the portfolio, ranked #53.

Vestal Point Capital first reported a position in OLMA in Q4 2025 and has held it in 4 quarters since. The position peaked at $41.2M in Q4 2025. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Vestal Point Capital held 420,000 shares of Olema Oncology worth $3.63M as of Q3 2026.
  • Vestal Point Capital bought 1,449 Olema Oncology shares in Q3 2026, an estimated $15.8K.
  • Olema Oncology made up 0.09% of Vestal Point Capital's portfolio in Q3 2026, its #53 holding.
  • Vestal Point Capital first reported a position in Olema Oncology in Q4 2025 and has held it in 4 quarters since.
  • Vestal Point Capital's Olema Oncology position peaked at $41.2M in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.